Close Menu
    Cairo ViewsCairo Views
    • Automotive
    • Business
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    Cairo ViewsCairo Views
    Home » RevitaLash® Cosmetics Announces New Milestone of Over $9 Million Committed to the Fight Against Breast Cancer
    PR Newswire

    RevitaLash® Cosmetics Announces New Milestone of Over $9 Million Committed to the Fight Against Breast Cancer

    October 1, 2024
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    VENTURA, Calif., Oct. 1, 2024 /PRNewswire/ — RevitaLash® Cosmetics (“RevitaLash”), globally recognized for its innovative lash, brow, and hair beautification products, is deepening its commitment to the fight against breast cancer during Breast Cancer Awareness Month and beyond. The company has now reached the milestone of over $9 million in money, product, and support donated and investments made in cancer research and patient care initiatives since 2008.

    RevitaLash Cosmetics Eternally Pink

    Since its inception, RevitaLash Cosmetics has proudly championed the cause, driven by the legacy of its late Co-Founder, Gayle Brinkenhoff, who battled breast cancer with courage and grace.

    As part of its ongoing Eternally Pink® pledge, RevitaLash Cosmetics continues its year-round philanthropic mission by donating a portion of proceeds from every product sold to directly fund groundbreaking research and make lifesaving care accessible to more patients.

    The brand’s impact has been felt through global contributions to therapeutic services for cancer patients, nursing education, empowering fundraisers, and crucial grants supporting cutting-edge research in collaboration with key organizations like City of Hope, Brigham and Women’s Hospital, Future Dreams UK, and more.

    This year, by phasing out of the brand’s annual Global Pink packaging initiative, RevitaLash Cosmetics was able to save 30% on production costs, reinvesting those savings into their global giving budget, and enacting real and tangible change. In addition, the brand has continued their “365” matching initiative with international partners. So far this year, nearly 10 of the brand’s international distributors partners have already aligned with local breast cancer associated organizations through this program, solidifying partnerships with institutions such as Institute Rafael in Paris, which offers comprehensive post-cancer care to patients and their families. The brand has also been recognized for the second consecutive year by the White House for their unwavering efforts to create better treatments and access to cancer healthcare in the sub Sahara regions of Africa.

    “We’re incredibly proud to have reached the milestone of over $9 million committed to the fight against breast cancer,” says Dariel Sidney, Vice President of Global Philanthropy and Gayle Brinkenhoff’s eldest daughter. “We owe everything to our customers, whose purchases enable us to continue funding life-changing initiatives – together, we are helping to make a difference in the lives of those facing a difficult diagnosis, and helping bring the world closer to finding a cure.”

    RevitaLash Cosmetic’s “Eternally Pink” pledge is a year-round initiative. The iconic pink ribbon on every product serves as a reminder of this meaningful and ongoing commitment. Through this dedication, the brand reinforces its role as a philanthropic leader in the beauty industry, steadfast in its mission to help empower patients and survivors and to fund research for a cure.

    For more information on RevitaLash Cosmetics’ breast cancer initiatives or to learn how your purchase supports the cause, visit www.revitalash.com/pages/eternally-pink.

    About RevitaLash® Cosmetics
    RevitaLash Cosmetics is a worldwide leader in developing advanced lash, brow and hair beautification products. Established in 2006, the collection includes award-winning RevitaLash Advanced Eyelash Conditioner and RevitaBrow Advanced Eyebrow Conditioner, and is available in physician’s offices, spas, salons, and specialty retailers across 70+ countries. A supporter of non-profit breast cancer initiatives, RevitaLash Cosmetics donates a portion of proceeds to research and education initiatives, giving back to the breast cancer community year-round, not just in October. For information, visit www.revitalash.com.

    Photo – https://mma.prnewswire.com/media/2520068/RevitaLash_Cosmetics_Eternally_Pink.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/revitalash-cosmetics-announces-new-milestone-of-over-9-million-committed-to-the-fight-against-breast-cancer-302263789.html


    Related Posts

    Carestream Launches NEW Lux HD 35 and Lux HD 43 Detectors for Medical Imaging

    June 10, 2026

    Joining Hands Across Mounts and Seas, GAC Partners with TDA to Start a New Journey in Angola

    June 9, 2026

    Fastmarkets closes the CBAM pricing gap with daily view of carbon import costs

    June 9, 2026

    THE GORE® VIABAHN® FORTEGRA VENOUS STENT RECEIVES MDR APPROVAL

    June 9, 2026

    MUST Debuts All-Scenario Hybrid Energy Series at SNEC 2026

    June 9, 2026

    Changan launches new energy vehicle DEEPAL brand in Oman with advanced range extended electric vehicles

    June 8, 2026
    Latest News

    FAO backs $3.9bn GEF-9 funding for food security

    June 8, 2026

    Egypt GDP rises 5.2% as foreign reserves climb

    June 8, 2026

    Korean cosmetics exports hit US$5.6 billion in five months

    June 8, 2026

    WHO reports 507 Ebola cases across Congo and Uganda

    June 8, 2026

    UN envoy cites regional push to end Middle East conflict

    June 6, 2026

    Global health bodies seek $518 million for Ebola response

    June 6, 2026

    Investor interest lifts UAE real estate in global index

    June 5, 2026

    Abu Dhabi advances climate adaptation tools

    June 5, 2026
    © 2026 Cairo Views | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.